These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 34613858)

  • 1. Impact of local vaccine subsidization programs on the prevention of mumps in Japan.
    Miyazaki M; Obara T; Mano N
    Hum Vaccin Immunother; 2021 Nov; 17(11):4216-4224. PubMed ID: 34613858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measles, mumps, rubella prevention: how can we do better?
    Kauffmann F; Heffernan C; Meurice F; Ota MOC; Vetter V; Casabona G
    Expert Rev Vaccines; 2021 Jul; 20(7):811-826. PubMed ID: 34096442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Close the gap for routine mumps vaccination in Japan.
    Kitano T
    Hum Vaccin Immunother; 2021 Jan; 17(1):205-210. PubMed ID: 32530735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The elimination of indigenous measles, mumps, and rubella from Finland by a 12-year, two-dose vaccination program.
    Peltola H; Heinonen OP; Valle M; Paunio M; Virtanen M; Karanko V; Cantell K
    N Engl J Med; 1994 Nov; 331(21):1397-402. PubMed ID: 7969278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sentinel surveillance shows small decline in MMR coverage.
    Commun Dis Rep CDR Wkly; 1998 Sep; 8(36):317, 320. PubMed ID: 9782644
    [No Abstract]   [Full Text] [Related]  

  • 6. Cost-effectiveness analyses of monovalent mumps vaccination programs for Japanese children.
    Hoshi SL; Okubo R; Tabuchi K; Seposo X; Shono A; Kondo M
    Vaccine; 2022 Sep; 40(37):5513-5522. PubMed ID: 35965241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mumps: an Update on Outbreaks, Vaccine Efficacy, and Genomic Diversity.
    Lam E; Rosen JB; Zucker JR
    Clin Microbiol Rev; 2020 Mar; 33(2):. PubMed ID: 32102901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IAP Position Paper on Burden of Mumps in India and Vaccination Strategies.
    Vashishtha VM; Yadav S; Dabas A; Bansal CP; Agarwal RC; Yewale VN; Thacker N; Kamath SS; Mehta PJ
    Indian Pediatr; 2015 Jun; 52(6):505-14. PubMed ID: 26121728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterisation of measles after the introduction of the combined measles-mumps-rubella (MMR) vaccine in 2004 with focus on the laboratory data, 2016 to 2019 outbreak, Romania.
    Lazar M; Stănescu A; Penedos AR; Pistol A
    Euro Surveill; 2019 Jul; 24(29):. PubMed ID: 31339098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevaccination antibody screening and immunization program for healthcare personnel against measles, mumps, rubella, and varicella in a Japanese tertiary care hospital.
    Kanamori H; Tokuda K; Ikeda S; Endo S; Ishizawa C; Hirai Y; Takahashi M; Aoyagi T; Hatta M; Gu Y; Yano H; Weber DJ; Kaku M
    Tohoku J Exp Med; 2014 Oct; 234(2):111-6. PubMed ID: 25224029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of protective immunity of two-dose mumps-containing vaccine over time: concerns with the new strategy of the mumps immunization program in China.
    Wang D; Nie T; Pan F; Wang Y; Wang J; Qin W
    Hum Vaccin Immunother; 2021 Jul; 17(7):2072-2077. PubMed ID: 33545016
    [No Abstract]   [Full Text] [Related]  

  • 12. [Measles, mumps and rubella: vaccination rate and seroprevalence in 8th grade students of 8 different sites in Switzerland 1995/96].
    Stohrer-Draxl P; Amstad H; Grize L; Gassner M; Takken-Sahli K; Bourquin C; Braun-Fahrländer C
    Praxis (Bern 1994); 1999 Jun; 88(24):1069-77. PubMed ID: 10420798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Administration of measles-mumps-rubella vaccination with other childhood schedule vaccines.
    Heath TC; Burgess MA; O'Brien ED
    Commun Dis Intell; 1998 Aug; 22(8):159. PubMed ID: 9735551
    [No Abstract]   [Full Text] [Related]  

  • 14. Measles, mumps, and rubella: monitoring in Switzerland through a sentinel network, 1986-94. Sentinella Arbeitsgemeinschaft.
    Matter HC; Cloetta J; Zimmermann H
    J Epidemiol Community Health; 1995 Aug; 49 Suppl 1(Suppl 1):4-8. PubMed ID: 7561669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased measles-mumps-rubella (MMR) vaccine uptake in the context of a targeted immunisation campaign during a measles outbreak in a vaccine-reluctant community in England.
    Le Menach A; Boxall N; Amirthalingam G; Maddock L; Balasegaram S; Mindlin M
    Vaccine; 2014 Feb; 32(10):1147-52. PubMed ID: 24440207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Economic analysis of measles elimination program in the Republic of Korea, 2001: a cost benefit analysis study.
    Bae GR; Choe YJ; Go UY; Kim YI; Lee JK
    Vaccine; 2013 May; 31(24):2661-6. PubMed ID: 23602654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety concerns regarding combination vaccines: the experience in Japan.
    Andreae MC; Freed GL; Katz SL
    Vaccine; 2004 Sep; 22(29-30):3911-6. PubMed ID: 15364439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in the mumps vaccine coverage and incidence of mumps before and after the public subsidization program: A descriptive study using a population-based database in Japan.
    Sato S; Ono S; Sasabuchi Y; Uemura K; Yasunaga H
    Am J Infect Control; 2024 Sep; ():. PubMed ID: 39293675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [35-year measles, mumps, rubella vaccination assessment in France].
    Reinert P; Soubeyrand B; Gauchoux R
    Arch Pediatr; 2003 Nov; 10(11):948-54. PubMed ID: 14613687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends in varicella and mumps vaccination rates in children under 3 years of age in a tertiary children's hospital in Japan.
    Morikawa Y; Morino S; Ito K; Furuichi M; Miyokawa S; Shoji T; Horikoshi Y
    Pediatr Int; 2019 Sep; 61(9):882-888. PubMed ID: 31211889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.